September 13 is #WorldSepsisDay, and this year marks the 10th anniversary of the occasion. Events in all parts of the world are taking place to raise awareness for sepsis, a condition that annually accounts for at least 11 million deaths worldwide. Today, Swedish biotech company Aptahem has gathered prominent researchers in the field who will be talking about this deadly condition dubbed “the silent killer”, starting at 15.00 CET today.
Watch the seminar via the link below.
Date: Monday 13 september
Time: 15:00 – 17.30 CET
Place: Digital event
Aptahem introduction – Mikael Lindstam, CEO Aptahem
Sepsis; clinical manifestations, treatment and ongoing research – Mats Eriksson, Associate Professor, Section of Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Sweden
Sepsis – Laboratory diagnostics. A focus on neutrophils
Anders Larsson, Professor, Department of Clinical Chemistry and Pharmacology, Uppsala University, Sweden
Future diagnostics of sepsis – SepsIT
Anna-Karin Pernestig, Associate Professor in Biosciences, University of Skövde, Sweden
Aptahem – pågående forskning
Apta-1 – a drug candidate to fight sepsis – Luiza Jedlina, PhD, CSO Aptahem
Apta-1 and Covid-19 – Mingyao Liu, MD, Senior Scientist, Toronto General Hospital Research Institute, Canada
Sepsis meeting Apta-1 and Haemostasis – Magnus Grenegård, Professor, School of Medical Sciences, Örebro University, Sweden
Closure – Mikael Lindstam, CEO Aptahem
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.